4.77

38.69% -3.01

Cvrx Inc (CVRX)

Overview News Price History Option Chain Financials Why CVRX Down? Discussions Forecast

Cvrx Inc stock is traded at $4.77, with a volume of 1.86M. It is down -38.69% in the last 24 hours and down -34.39% over the past month. CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Previous Close:

$7.78

Open:

$5.97

24h Volume:

1.86M

Relative Volume:

5.80

Market Cap:

$206.99M

Revenue:

$47.26M

Net Income/Loss:

$-58.48M

P/E Ratio:

-1.7635

EPS:

-2.7049

Net Cash Flow:

$-40.45M

1W Performance:

-40.00%

1M Performance:

-34.39%

6M Performance:

-69.27%

1Y Performance:

-34.75%

1-Day Range:

$4.6101

$5.97

1-Week Range:

$4.6101

$7.95

52-Week Range:

$4.6101

$18.55

Cvrx Inc Stock (CVRX) Company Profile

Name

Cvrx Inc

Sector

Healthcare (1153)

Industry

Medical Devices (157)

Phone

(763) 416-2850

Address

9201 WEST BROADWAY AVENUE, MINNEAPOLIS

Employee

206

Twitter

Next Earnings Date

2025-02-04

Latest SEC Filings

CVRX's Discussions on Twitter

Compare CVRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CVRX Cvrx Inc	4.77	206.99M	47.26M	-58.48M	-40.45M	-2.7049
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Cvrx Inc Stock (CVRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-09-25	Downgrade	JP Morgan	Neutral → Underweight
Jan-14-25	Upgrade	William Blair	Mkt Perform → Outperform
Sep-10-24	Initiated	Cantor Fitzgerald	Overweight
Jul-11-24	Reiterated	Lake Street	Buy
May-01-24	Resumed	Craig Hallum	Buy
May-01-24	Downgrade	JP Morgan	Overweight → Neutral
May-01-24	Downgrade	William Blair	Outperform → Mkt Perform
Jan-31-23	Initiated	Lake Street	Buy
Jul-18-22	Initiated	Craig Hallum	Buy
Jul-26-21	Initiated	Canaccord Genuity	Buy
Jul-26-21	Initiated	Piper Sandler	Overweight
Jul-26-21	Initiated	William Blair	Outperform

View All

Cvrx Inc Stock (CVRX) Latest News

08:19 AM

CVRx, Inc. (NASDAQ:CVRX) Q1 2025 Earnings Call Transcript - Insider Monkey

08:19 AM

Cvrx Inc (CVRX)

Cvrx Inc Stock (CVRX) Company Profile

Compare CVRX with other stocks

Cvrx Inc Stock (CVRX) Upgrades & Downgrades

Cvrx Inc Stock (CVRX) Latest News

CVRx, Inc. (NASDAQ:CVRX) Q1 2025 Earnings Call Transcript - Insider Monkey

JPMorgan cuts CVRx stock rating, slashes price target to $7 By Investing.com - Investing.com India

CVRx (CVRX) Sees Downgrade and Price Target Reduction from JP Mo - GuruFocus

CVRx Earnings Call: Growth Amidst Challenges - TipRanks

CVRx (CVRX) Shares Fall Following Q1 Sales Miss and Downgrade - GuruFocus

CVRx price target lowered to $12 from $20 at Piper Sandler - TipRanks

JPMorgan cuts CVRx stock rating, slashes price target to $7 - Investing.com

CVRx stock downgraded at J.P. Morgan on Q1 miss (CVRX:NASDAQ) - Seeking Alpha

Demystifying CVRx: Insights From 4 Analyst Reviews - Benzinga

Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and CVRx (CVRX) - The Globe and Mail

Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25% - simplywall.st

This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga

This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga

JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15 - marketscreener.com

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

CVRx Q1 2025 revenue increases 15% to USD 12.3 million - Medical Buyer

CVRx: Q1 Earnings Snapshot - New Haven Register

CVRx downgraded to Underweight from Neutral at JPMorgan - TipRanks

CVRx Q1 2025 Earnings Call Transcript - MarketBeat

Earnings call transcript: CVRx Q1 2025 shows improved EPS, stock dips - Investing.com Nigeria

CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

CVRx Reports First Quarter 2025 Financial and Operating Results - GlobeNewswire

CVRx Inc reports results for the quarter ended March 31Earnings Summary - TradingView

CVRx, Inc. Reports Revenue Growth in Q1 2025 - TipRanks

What To Expect From CVRx Inc (CVRX) Q1 2025 Earnings - Yahoo Finance

Renaissance Technologies LLC Purchases Shares of 40,200 CVRx, Inc. (NASDAQ:CVRX) - Defense World

CVRx Inc (CVRX) Is A Possible Investment At Current Levels - Stocksregister

CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

(CVRX) Proactive Strategies - news.stocktradersdaily.com

CVRx Inc Inc. (CVRX) Price Performance: The Role of Supply and Demand - investchronicle.com

$CVRX stock is up 8% today. Here's what we see in our data. - Nasdaq

Geode Capital Management LLC Has $4.11 Million Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World

Press Release Distribution & PR Platform - ACCESS Newswire

CVRx, Inc. to Announce Q1 2025 Financial Results on May 8, 2025 - Nasdaq

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025 - GlobeNewswire

Russell Investments Group Ltd. Invests $455,000 in CVRx, Inc. (NASDAQ:CVRX) - Defense World

CVRx Sets Q1 2025 Earnings Release: Key Financial Updates Coming May 8How to Join Live - Stock Titan

CVRx, Inc. (NASDAQ:CVRX) Shares Sold by Alliancebernstein L.P. - Defense World

Buying CVRx Inc (NASDAQ: CVRX)? Here Are Some Things To Consider - Stocksregister

CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by JPMorgan Chase & Co. - Defense World

CVRx, Inc. (NASDAQ:CVRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

(CVRX) Investment Analysis - news.stocktradersdaily.com

Cantor maintains CVRx stock with $20 target despite revenue miss By Investing.com - Investing.com India

Cantor maintains CVRx stock with $20 target despite revenue miss - Investing.com Australia

William Blair Comments on CVRx’s Q1 Earnings (NASDAQ:CVRX) - Defense World

Canaccord Genuity Group Cuts CVRx (NASDAQ:CVRX) Price Target to $18.00 - Defense World

CVRx's SWOT analysis: barostim maker's stock faces growth hurdles By Investing.com - Investing.com India

CVRx stock slides on preliminary revenue miss - MSN

CVRx, Inc.: Overreaction Creates Buying Opportunity - Seeking Alpha

CVRx Insiders Lose Out As Stock Sinks To US$6.20 - simplywall.st

CVRx’s SWOT analysis: barostim maker’s stock faces growth hurdles By Investing.com - Investing.com India

Cvrx Inc Stock (CVRX) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to CVRX